ro 11-2933 has been researched along with rhodamine 123 in 2 studies
| Studies (ro 11-2933) | Trials (ro 11-2933) | Recent Studies (post-2010) (ro 11-2933) | Studies (rhodamine 123) | Trials (rhodamine 123) | Recent Studies (post-2010) (rhodamine 123) |
|---|---|---|---|---|---|
| 13 | 0 | 0 | 1,760 | 10 | 424 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Patterson, FK; Wigler, PW | 1 |
| Bines, SD; Chong, AS; Coon, JS; Gebel, HM; Markham, PN | 1 |
2 other study(ies) available for ro 11-2933 and rhodamine 123
| Article | Year |
|---|---|
Reversal agent inhibition of the multidrug resistance pump in human leukemic lymphoblasts.
Topics: Amiodarone; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cyclosporine; Drug Resistance; Humans; Leukemia; Membrane Glycoproteins; Propranolol; Propylamines; Quinidine; Quinine; Rhodamine 123; Rhodamines; Stereoisomerism; Tumor Cells, Cultured | 1994 |
Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Cytotoxicity, Immunologic; Dose-Response Relationship, Drug; Drug Resistance; Humans; Killer Cells, Natural; Membrane Glycoproteins; Propylamines; Rhodamine 123; Rhodamines; Verapamil | 1993 |